Drug Identification System

PillID

← Blog 🌙

What Is the A333 Pill? Oxycodone/Acetaminophen Identification

The A333 pill is a white oblong tablet containing oxycodone hydrochloride 10mg combined with acetaminophen 325mg. It is manufactured by Actavis (now part of the Allergan/Teva portfolio) and is a generic equivalent of Percocet 10/325 — one of the most recognized opioid combination brand names in American medicine. The "A" in the imprint is Actavis's manufacturer identifier. This tablet represents a 10mg oxycodone formulation, which is at the higher end of typical oxycodone/acetaminophen combination product strengths, and carries significant considerations around both the opioid and acetaminophen components.

About Actavis and the A333 Imprint

Actavis was one of the largest generic pharmaceutical companies in the world, headquartered in Parsippany, New Jersey (with roots in Iceland). The company grew through a series of acquisitions, including the purchase of Watson Pharmaceuticals in 2012 — which is why some Actavis products bear the "Watson" legacy and others carry the "A" imprint reflecting the Actavis brand. In 2015, Actavis acquired Allergan and adopted the Allergan name for the combined entity. The generics division was subsequently divested to Teva Pharmaceuticals in 2016.

The A333 imprint was introduced as part of the Actavis generic oxycodone/acetaminophen product line. Equivalent formulations from successor entities may bear different imprints, but databases still reference A333 as a valid, identifiable imprint for oxycodone 10mg/acetaminophen 325mg.

Drug Class and Mechanism of Action

The A333 tablet combines two distinct analgesic agents with complementary mechanisms:

Oxycodone — Semi-Synthetic Opioid Analgesic

Oxycodone is derived from thebaine, an alkaloid found in the opium poppy. As a full agonist at mu-opioid receptors, oxycodone produces potent analgesia by engaging the brain and spinal cord's endogenous opioid system. Mu-receptor activation in pain-processing regions — the periaqueductal gray, rostral ventromedial medulla, and spinal cord dorsal horn — inhibits both the transmission of nociceptive signals and the emotional suffering associated with pain. Simultaneously, opioid receptors in the limbic system mediate euphoria, which underlies oxycodone's significant abuse liability.

Oxycodone is metabolized by hepatic CYP3A4 (to noroxycodone) and CYP2D6 (to oxymorphone, a potent active metabolite). CYP3A4 inhibitors — including certain antifungals (ketoconazole), macrolide antibiotics (clarithromycin), and grapefruit — can substantially increase oxycodone plasma levels and risk of toxicity. CYP3A4 inducers (rifampin, certain anticonvulsants) can reduce efficacy.

Acetaminophen — Analgesic and Antipyretic

The 325mg acetaminophen component provides supplemental analgesia through mechanisms involving central COX inhibition and modulation of descending serotonergic pathways. The clinical rationale for combining oxycodone with acetaminophen is pharmacological synergy — the combination produces greater analgesia than either agent alone at the same individual doses, allowing a lower oxycodone dose to achieve adequate pain control (the opioid-sparing principle). This reduces some opioid-related side effects while maintaining therapeutic efficacy.

What Is the A333 Pill Prescribed For?

Oxycodone/acetaminophen 10mg/325mg is prescribed for moderate to severe pain in patients for whom combination opioid therapy is clinically appropriate. At the 10mg oxycodone strength, this formulation is typically reserved for patients with established opioid tolerance or significant pain that has not been adequately managed with lower-strength formulations. Clinical contexts include:

• Post-surgical pain: Major surgical procedures where significant post-operative pain is anticipated and short-term opioid therapy is part of the recovery plan
• Acute severe pain: Traumatic injury, orthopedic fractures, or other acute painful conditions requiring strong analgesia
• Cancer pain: Opioid analgesics remain central to cancer pain management per WHO guidelines; combination products may be appropriate for patients with moderate to severe cancer-related pain
• Chronic non-cancer pain: In selected patients where opioid therapy has been deemed appropriate after thorough evaluation, the 10mg strength may be used as part of an ongoing pain management regimen — though prescribing of this strength for chronic non-cancer pain has decreased substantially as clinical guidelines have evolved

Side Effects and Risks

Oxycodone-Related Effects

• Sedation and impaired cognition: Drowsiness, confusion, slowed thinking, and impaired motor coordination are common. Activities requiring alertness — driving, operating machinery — are dangerous during opioid therapy.
• Nausea and vomiting: Mediated centrally through the chemoreceptor trigger zone in the brainstem. Often improves with ongoing use as tolerance develops to this effect.
• Constipation: Opioid-induced bowel dysfunction affects nearly all patients on opioid therapy and does not remit meaningfully with continued use. Proactive bowel regimen management is essential.
• Respiratory depression: Dose-dependent suppression of ventilatory drive. The primary mechanism of opioid overdose death. Risk is dramatically amplified by concurrent benzodiazepines, alcohol, or other CNS depressants — combinations responsible for a disproportionate share of overdose fatalities.
• Physical dependence: Develops with regular use. The nervous system adapts to opioid exposure; abrupt discontinuation precipitates withdrawal. This is a physiological adaptation, distinct from opioid use disorder, but must be managed with supervised tapering when discontinuing therapy.
• Opioid use disorder: Oxycodone carries high addiction liability. The 10mg strength, representing a higher opioid dose, carries correspondingly greater risk compared to lower-strength formulations.

Acetaminophen-Related Risk: Hepatotoxicity

Acetaminophen is the most common cause of acute liver failure in the United States and many other developed nations. While 325mg per tablet is a modest per-dose amount, cumulative daily intake from all sources must be carefully tracked. Patients taking A333 who also use any of the following are at risk of exceeding safe limits:

• Over-the-counter Tylenol or generic acetaminophen
• OTC cold, flu, or sleep medications (many contain acetaminophen)
• Other prescription combination pain products
• Alcohol — which dramatically potentiates acetaminophen hepatotoxicity even at normal doses through induction of CYP2E1 (which converts acetaminophen to the hepatotoxic metabolite NAPQI) and depletion of hepatic glutathione

Patients with pre-existing liver disease, those who drink alcohol regularly, or those who are malnourished face heightened risk and should use acetaminophen-containing products only under close medical supervision. Symptoms of acetaminophen overdose — nausea, abdominal pain, jaundice — may be delayed by 24–72 hours after ingestion, making early medical evaluation critical if overdose is suspected.

What to Do If You Find an A333 Tablet

Finding a white oblong tablet stamped "A333" warrants several important steps:

• Confirm identification using a pill identifier tool such as PillID, or by calling your pharmacist. Pharmacists can confirm pill identity quickly and at no cost.
• Do not take it without a valid prescription. Oxycodone/acetaminophen 10/325 is a Schedule II controlled substance. Taking it without a prescription is illegal and carries real overdose risk, particularly for anyone without opioid tolerance.
• Do not share it. Transferring Schedule II medications is a federal crime. It is also medically dangerous — the opioid doses in this tablet can be fatal to opioid-naive individuals.
• Dispose of it properly. Use a DEA-authorized medication take-back event or a pharmacy drop box. Safe disposal removes the risk of accidental ingestion, child access, and diversion.

Frequently Asked Questions

What is the A333 pill?

The A333 pill is a white oblong tablet containing oxycodone 10mg and acetaminophen 325mg — the generic equivalent of Percocet 10/325 — manufactured by Actavis (now part of the Teva portfolio). The "A" in the imprint is Actavis's manufacturer identifier. It is a Schedule II controlled substance prescribed for moderate to severe pain that requires a written prescription for every dispensing, with no refills permitted.

Why does the A333 contain both oxycodone and acetaminophen?

Combining oxycodone with acetaminophen provides greater pain relief than either drug alone at equivalent individual doses — a pharmacological effect called opioid sparing. The acetaminophen acts through a different mechanism (central COX inhibition and serotonergic modulation), allowing a lower oxycodone dose to achieve adequate analgesia, which can reduce some opioid-related side effects while maintaining therapeutic efficacy.

Do I need to monitor my total acetaminophen intake while taking A333?

Yes, this is critically important. While 325mg per tablet is modest, acetaminophen is present in hundreds of OTC products — including cold medicines, sleep aids, and other pain relievers — and cumulative daily intake from all sources must be tracked carefully. Excessive acetaminophen is the leading cause of acute liver failure in the United States. Alcohol dramatically increases the liver-damaging effect of acetaminophen even at normal doses.

Are counterfeit A333 pills dangerous?

Extremely so. White oblong opioid tablets are among the most frequently counterfeited pharmaceutical forms in the U.S. DEA laboratory analysis has confirmed counterfeit tablets mimicking A333 that contain illicitly manufactured fentanyl — which is 50–100 times more potent than morphine by weight. A quantity of fentanyl invisible to the naked eye can cause fatal respiratory depression. No visual feature can reliably distinguish a genuine pharmaceutical from a counterfeit; only pills from a licensed pharmacy can be trusted.